3

01244

3D Medicines

3.675

+1.495+68.58%
Opening10:24 08/20 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE2.675/2.180
TODAY RANGE2.675-5.000
VOL3.97M
MARKET CAP882.97M
52 WEEK RANGE1.820-10.020
AVG VOL (3M)232.56K
% TURNOVER1.54%
TURNOVER13.94M
P/E (TTM)-4.492
% RANGE106.65%
EPS(TTM)-0.761
P/E(FORWARD)--
P/B1.336
BVPS2.559
DIVIDEND--
P/S2.240
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP882.97M
SHARES OUTSTANDING258.18M
NEXT EARNINGS--
FREE FLOAT258.18M
LOT SIZE500
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

3

3D Medicines

01244

+68.58%
3.675

04332

--

藥明康德

02359

-1.56%
202.000

海螺創業

00586

+0.46%
8.710

06821

--

01099

--

00874

--

01513

--

上海醫藥

02607

-1.71%
11.530

復星醫藥

02196

+7.71%
18.030

C

China Medical System Holdings

00867

-0.34%
11.700

06600

--

W

Wuxi Biologics (Cayman)

02269

-1.40%
47.900

中國同輻

01763

-1.75%
16.300

C

China Shineway Pharmaceutical Group

02877

+2.94%
8.230

聯邦制藥

03933

-1.36%
8.685

01681

--

三生製藥

01530

-1.77%
16.690

00719

--

同仁堂國藥

03613

-0.15%
6.475

C

China Resources Pharmaceutical Group

03320

-1.22%
4.860

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.